Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “First Line Metastatic Colorectal Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06728072
What this trial is testing

Addition of Antibiotics to Upfront Treatment Regimen for Colorectal Cancer

Who this might be right for
Colorectal CancerCRC
Virginia Commonwealth University 97
Large-scale testing (Phase 3)Looking for participantsNCT07309289
What this trial is testing

NALIRIFOX Plus Targeted Therapy Versus FOLFOX Plus Targeted Therapy as First-line Treatment for Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer (CRC)
Shanghai Zhongshan Hospital 144
Testing effectiveness (Phase 2)Looking for participantsNCT07718490
What this trial is testing

Immunotheray Combined With Simvastatin and Target Therapy and Chemotharepy for Advanced Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
The First Affiliated Hospital with Nanjing Medical University 43
Testing effectiveness (Phase 2)Looking for participantsNCT06493760
What this trial is testing

SSGJ-707 in Metastatic Colorectal Cancer Patients

Who this might be right for
Metastatic Colorectal Cancer
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 130
Not applicableStudy completedNCT02872779
What this trial is testing

Correlation Between Circulating Tumour Markers Early Variations and Clinical Response in First Line Treatment of Metastatic Colorectal Cancer

Who this might be right for
Circulating MarkersMetastatic Colorectal Cancer
University Hospital, Rouen 74
Testing effectiveness (Phase 2)Ended earlyNCT06332079
What this trial is testing

Holmium-166 TARE in Liver Limited Unresectable Colorectal Cancer Patients

Who this might be right for
Colorectal Cancer Metastatic
Gruppo Oncologico del Nord-Ovest 4
Large-scale testing (Phase 3)Looking for participantsNCT04547166
What this trial is testing

A Clinical Study to Evaluate Efficacy and Safety of Serplulimab（HLX10） Combined With Bevacizumab（HLX04) and Chemotherapy (XELOX) in Patients With Metastatic Colorectal Cancer (mCRC)

Who this might be right for
Metastatic Colorectal Cancer
Shanghai Henlius Biotech 568
Not applicableUnknownNCT02254941
What this trial is testing

Observational Study to Evaluate the Use of Targeted Therapies in Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colon Cancer
Grupo Espanol Multidisciplinario del Cancer Digestivo 1,104
Large-scale testing (Phase 3)Looking for participantsNCT07669454
What this trial is testing

A Randomized, Double-blind, Placebo-controlled, Parallel-group, Comparative, Phase III Study to Evaluate the Efficacy and Safety of Nuvastatic® 300mg Capsule in Reducing Cancer-Tumor in Patients With Metastatic Colorectal Cancer Receiving Standard Chemotherapy.

Who this might be right for
Fatigue Related to Cancer TreatmentColon Cancer
Natureceuticals Sdn Bhd 250
Post-approval studies (Phase 4)Study completedNCT00577031
What this trial is testing

OBELIX Study: A Study of Avastin (Bevacizumab) in Combination With XELOX in Patients With Metastatic Cancer of the Colon or Rectum.

Who this might be right for
Colorectal Cancer
Hoffmann-La Roche 205
Large-scale testing (Phase 3)Study completedNCT01878422
What this trial is testing

Sequential Treatment Strategy for Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 376
Testing effectiveness (Phase 2)Looking for participantsNCT05959356
What this trial is testing

Cetuximab and Envafolimab Plus mFOLFOXIRI as First-line Treatment for RAS/BRAF Wild-type, MSS, Unresectable Left-side Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Sun Yat-sen University 198
Testing effectiveness (Phase 2)Study completedNCT00862784
What this trial is testing

IMC-1121B (Ramucirumab) in Colorectal Cancer

Who this might be right for
Colorectal Carcinoma
Eli Lilly and Company 48
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06195670
What this trial is testing

Clinical Study of Short-course Radiotherapy Followed by Fruquintinib Plus Sintilimab vs Bevacizumab Plus Capecitabine as First Line Treatment in Advanced mCRC

Who this might be right for
CRCMetastatic Colorectal CancerMetastatic Colorectal Adenocarcinoma
Zhejiang Cancer Hospital 220
Testing effectiveness (Phase 2)Study completedNCT01490866
What this trial is testing

A Trial of Single Agent Axitinib as Maintenance Therapy for Patients With First Line Metastatic Colorectal Cancer (mCRC)

Who this might be right for
Colorectal Cancer
SCRI Development Innovations, LLC 70
Testing effectiveness (Phase 2)Study completedNCT00891332
What this trial is testing

Study of S-1 Plus LV for Untreated Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Taiho Pharmaceutical Co., Ltd. 73
Testing effectiveness (Phase 2)Study completedNCT00089401
What this trial is testing

Isolated Hepatic Perfusion With Melphalan in Treating Patients With Unresectable Colorectal Cancer That Has Metastasized to the Liver

Who this might be right for
Colorectal CancerMetastatic Cancer
National Institutes of Health Clinical Center (CC) 8
Testing effectiveness (Phase 2)Ended earlyNCT00609622
What this trial is testing

Randomized Study Of Sunitinib Plus FOLFOX Versus Bevacizumab Plus FOLFOX In Metastatic Colorectal Cancer

Who this might be right for
Colorectal Neoplasms
Pfizer 191
Large-scale testing (Phase 3)Looking for participantsNCT02885753
What this trial is testing

Systemic Oxaliplatin or Intra-arterial Chemotherapy Combined With LV5FU2 +/- Irinotecan and an Target Therapy in First Line Treatment of Metastatic Colorectal Cancer Restricted to the Liver

Who this might be right for
Colorectal Neoplasms
Federation Francophone de Cancerologie Digestive 348
Not applicableEnded earlyNCT02511756
What this trial is testing

Visualization of Anti-angiogenic Effects With Perfusion Computed Tomography (CTP)

Who this might be right for
Metastatic Colorectal Cancer
Patrick Veit-Haibach 50
Next Page